{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:48:09Z","timestamp":1791470889132,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2023AAC02069"],"award-info":[{"award-number":["2023AAC02069"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031935","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","award":["XJTU1AF2022LSL-014"],"award-info":[{"award-number":["XJTU1AF2022LSL-014"]}],"id":[{"id":"10.13039\/100031935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bcp.2025.117031","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:04:53Z","timestamp":1749035093000},"page":"117031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["PCSK9 inhibition mitigates vulnerable plaque formation induced by hyperhomocysteinemia through regulating lipid metabolism and inflammation"],"prefix":"10.1016","volume":"239","author":[{"given":"Ping","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1475-5183","authenticated-orcid":false,"given":"Qiangsun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7855","key":"10.1016\/j.bcp.2025.117031_b0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"10278","key":"10.1016\/j.bcp.2025.117031_b0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2025.117031_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41569-022-00769-8","article-title":"Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research","volume":"20","author":"Gaba","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117031_b0020","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117031_b0025","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/CIRCRESAHA.123.321563","article-title":"HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy","volume":"132","author":"Linton","year":"2023","journal-title":"Circ. Res."},{"issue":"25","key":"10.1016\/j.bcp.2025.117031_b0030","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/eurheartj\/ehv653","article-title":"Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque","volume":"37","author":"Janoudi","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bcp.2025.117031_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/ehn515","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.bcp.2025.117031_b0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12272-018-1016-4","article-title":"Causes of hyperhomocysteinemia and its pathological significance","volume":"41","author":"Kim","year":"2018","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2025.117031_b0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2017.00324","article-title":"Hyperhomocysteinemia, Suppressed Immunity, and Altered Oxidative Metabolism Caused by Pathogenic Microbes in Atherosclerosis and Dementia","volume":"9","author":"McCully","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"20","key":"10.1016\/j.bcp.2025.117031_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207698","article-title":"Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems","volume":"21","author":"Kaplan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117031_b0055","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3724\/abbs.2022093","article-title":"Extracellular-superoxide dismutase DNA methylation promotes oxidative stress in homocysteine-induced atherosclerosis","volume":"54","author":"Ma","year":"2022","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.bcp.2025.117031_b0060","article-title":"Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis","volume":"9","author":"Yuan","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2025.117031_b0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","article-title":"Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall","volume":"173","author":"Balint","year":"2020","journal-title":"Biochimie"},{"issue":"11","key":"10.1016\/j.bcp.2025.117031_b0070","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2007.1750","article-title":"Vascular oxidant stress and inflammation in hyperhomocysteinemia","volume":"9","author":"Papatheodorou","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.117031_b0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2018.10.060","article-title":"Homocysteine accelerates atherosclerosis via inhibiting LXR\u03b1-mediated ABCA1\/ABCG1-dependent cholesterol efflux from macrophages","volume":"214","author":"Jin","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2025.117031_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105974","article-title":"SNF5 promotes IL-1\u03b2 expression via H3K4me1 in atherosclerosis induced by homocysteine","volume":"135","author":"Xie","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117031_b0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117031_b0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11883-022-01057-z","article-title":"Expanding Biology of PCSK9: Roles in Atherosclerosis and beyond","volume":"24","author":"Seidah","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.bcp.2025.117031_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1431398","article-title":"The role of proprotein convertase subtilisin\/kexin 9 (PCSK9) in macrophage activation: a focus on its LDL receptor-independent mechanisms","volume":"11","author":"Katsuki","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117031_b0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIRCRESAHA.121.320056","article-title":"Proprotein Convertase Subtilisin\/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms","volume":"131","author":"Katsuki","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2025.117031_b0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2017.04.023","article-title":"New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4\/NF-\u03baB pathway","volume":"262","author":"Tang","year":"2017","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.bcp.2025.117031_b0110","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/cvr\/cvaa254","article-title":"PCSK9 and LRP5 in macrophage lipid internalization and inflammation","volume":"117","author":"Badimon","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117031_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.746989","article-title":"Role of PCSK9 in homocysteine-accelerated lipid accumulation in macrophages and atherosclerosis in ApoE(-\/-) mice","volume":"8","author":"Jin","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117031_b0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10557-020-07041-6","article-title":"PCSK9Q\u03b2-003 Vaccine Attenuates Atherosclerosis in Apolipoprotein E-Deficient mice","volume":"35","author":"Wu","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"11","key":"10.1016\/j.bcp.2025.117031_b0125","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bcp.2025.117031_b0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2017.02.006","article-title":"Dual signaling evoked by oxidized LDLs in vascular cells","volume":"106","author":"N\u00e8gre-Salvayre","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117031_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcmm.12689","article-title":"Macrophage-mediated cholesterol handling in atherosclerosis","volume":"20","author":"Chistiakov","year":"2016","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117031_b0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/abbs\/gms119","article-title":"Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells","volume":"45","author":"Liang","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117031_b0145","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.atherosclerosis.2007.09.014","article-title":"Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression","volume":"197","author":"Thampi","year":"2008","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.bcp.2025.117031_b0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jep.2011.01.021","article-title":"Aged garlic extract inhibits homocysteine-induced scavenger receptor CD36 expression and oxidized low-density lipoprotein cholesterol uptake in human macrophages in vitro","volume":"134","author":"Morihara","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2025.117031_b0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2019.11.145","article-title":"Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b\/SP1 pathway","volume":"138","author":"Guo","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2025.117031_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2016.11.019","article-title":"Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages","volume":"256","author":"Adorni","year":"2017","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bcp.2025.117031_b0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08916934.2022.2051142","article-title":"Inclisiran inhibits oxidized low-density lipoprotein-induced foam cell formation in Raw264.7 macrophages via activating the PPAR\u03b3 pathway","volume":"55","author":"Wang","year":"2022","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.bcp.2025.117031_b0170","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.3892\/mmr.2016.4975","article-title":"Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice","volume":"13","author":"Jia","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2025.117031_b0175","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.3892\/mmr.2017.7753","article-title":"Homocysteine\u2011induced oxidative stress through TLR4\/NF\u2011\u03baB\/DNMT1\u2011mediated LOX\u20111 DNA methylation in endothelial cells","volume":"16","author":"Ma","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117031_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12944-025-02443-7","article-title":"Mutual mediation effects of homocysteine and PCSK9 on coronary lesion severity in patients with acute coronary syndrome: interplay with inflammatory and lipid markers","volume":"24","author":"Jin","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.bcp.2025.117031_b0185","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cvr\/cvae109","article-title":"Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial","volume":"120","author":"Wright","year":"2024","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117031_b0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamacardio.2024.1659","article-title":"Efficacy and Safety of Lerodalcibep in patients with or at High risk of Cardiovascular Disease: a Randomized Clinical Trial","volume":"9","author":"Klug","year":"2024","journal-title":"JAMA Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117031_b0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jcmg.2021.11.014","article-title":"Determinants of Plaque Progression despite very Low Low-Density Lipoprotein-Cholesterol Levels with the PCSK9 Inhibitor","volume":"15","author":"Honda","year":"2022","journal-title":"Evolocumab, JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.bcp.2025.117031_b0200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12916-024-03823-z","article-title":"The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: a multicenter study","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.bcp.2025.117031_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156064","article-title":"PCSK9 in metabolism and diseases","volume":"163","author":"Ajoolabady","year":"2025","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.bcp.2025.117031_b0210","article-title":"Prevalence of Hyperhomocysteinemia in China: An Updated Meta-Analysis","volume":"10","author":"Zeng","year":"2021","journal-title":"Biology (Basel)"},{"issue":"8","key":"10.1016\/j.bcp.2025.117031_b0215","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacasi.2024.05.005","article-title":"Homocysteine metabolism, subclinical myocardial injury, and cardiovascular mortality in the general population","volume":"4","author":"Tan","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.bcp.2025.117031_b0220","article-title":"Homocysteine Promotes the Pathogenesis of Atherosclerosis through the Circ-PIAS1-5\/miR-219a-2-3p\/TEAD1 Axis","author":"Ma","year":"2025","journal-title":"Adv Sci (weinh)"},{"issue":"6","key":"10.1016\/j.bcp.2025.117031_b0225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117031_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.953845","article-title":"Sex difference in circulating PCSK9 and its clinical implications","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2025.117137","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:23:04Z","timestamp":1762096984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S0006295225002965"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117031","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 inhibition mitigates vulnerable plaque formation induced by hyperhomocysteinemia through regulating lipid metabolism and inflammation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117031"}}